Clinical Trial Update: Irinotecan (Camptosar) in Patients With Advanced Sarcomas [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating irinotecan (Camptosar) in patients with advanced sarcomas has completed and reported results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Camptosar (irinotecan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Sarcoma | Phase 2 | Status: COMPLETED